Predicting Radiation-Induced Heart Disease and Survival-Is Location the Key?

[1]  R. Mak,et al.  Association of Left Anterior Descending Coronary Artery Radiation Dose With Major Adverse Cardiac Events and Mortality in Patients With Non-Small Cell Lung Cancer. , 2020, JAMA oncology.

[2]  Joseph O. Deasy,et al.  Modeling the Impact of Cardiopulmonary Irradiation on Overall Survival in NRG Oncology Trial RTOG 0617 , 2020, Clinical Cancer Research.

[3]  P. Brown,et al.  Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Zuofeng Li,et al.  The Meaningless Meaning of Mean Heart Dose in Mediastinal Lymphoma in the Modern Radiotherapy Era. , 2020, Practical radiation oncology.

[5]  A. Louie,et al.  Is the Importance of Heart Dose Overstated in the Treatment of Non-Small Cell Lung Cancer? A Systematic Review of the Literature. , 2019, International journal of radiation oncology, biology, physics.

[6]  L. Holmberg,et al.  The relationship between radiation doses to coronary arteries and location of coronary stenosis requiring intervention in breast cancer survivors , 2019, Radiation oncology.

[7]  Sinae Kim,et al.  Dosimetric Predictors of Symptomatic Cardiac Events After Conventional‐Dose Chemoradiation Therapy for Inoperable NSCLC , 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[8]  M. Socinski,et al.  Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancer. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  Marcel van Herk,et al.  Radiation dose to heart base linked with poorer survival in lung cancer patients. , 2017, European journal of cancer.

[10]  J. Sonke,et al.  Dose to heart substructures is associated with non-cancer death after SBRT in stage I-II NSCLC patients. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  S. Jolly,et al.  Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non-Small-Cell Lung Cancer. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  J. Bradley,et al.  Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non–Small Cell Lung Cancer , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[13]  C. Grines,et al.  SCAI Expert consensus statement: Evaluation, management, and special considerations of cardio‐oncology patients in the cardiac catheterization laboratory (endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologıa intervencionista) , 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[14]  C. Grines,et al.  SCAI Expert consensus statement: Evaluation, management, and special considerations of cardio‐oncology patients in the cardiac catheterization laboratory (endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologıa intervencionista) , 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[15]  P. Hall,et al.  Risk of ischemic heart disease in women after radiotherapy for breast cancer. , 2013, The New England journal of medicine.